Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
Baxter
Julphar
McKesson
Citi

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,765,353

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,765,353
Title:Plant having suppressed expression of glycoalkaloid biosynthetic enzyme gene or altered activity of the enzyme
Abstract: Provided are the DNA of a glycoalkaloid biosynthetic enzyme of solanaceous plants (Solanaceae) such as potato, solanaceous plants producing no glycoalkaloids, and a method of producing a cultivar with a reduced risk of accumulating glycoalkaloids, which involves crossing plants in which the expression of an oxidase gene involved in glycoalkaloid biosynthesis is suppressed or the activity of the enzyme is lowered, as mother plants, and screening progeny resulting from the crossing.
Inventor(s): Umemoto; Naoyuki (Nakano-ku, JP)
Assignee: KIRIN HOLDINGS KABUSHIKI KAISHA (Nakano-ku, Tokyo, JP)
Application Number:14/382,913
Patent Claims:see list of patent claims

Details for Patent 9,765,353

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial KIRIN HOLDINGS KABUSHIKI KAISHA (Nakano-ku, Tokyo, JP) 2032-03-07 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial KIRIN HOLDINGS KABUSHIKI KAISHA (Nakano-ku, Tokyo, JP) 2032-03-07 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial KIRIN HOLDINGS KABUSHIKI KAISHA (Nakano-ku, Tokyo, JP) 2032-03-07 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Citi
Colorcon
Merck
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.